Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Oncogenic properties of sphingosine kinases in haematological malignancies
Author: Wallington-Beddoe, C.
Bradstock, K.
Bendall, L.
Citation: British Journal of Haematology, 2013; 161(5):623-638
Publisher: John Wiley & Sons
Issue Date: 2013
ISSN: 0007-1048
Statement of
Craig T. Wallington-Beddoe, Kenneth F. Bradstock and Linda J. Bendall
Abstract: The sphingosine kinases (SphKs) have relatively recently been implicated in contributing to malignant cellular processes with particular interest in the oncogenic properties of SPHK1. Whilst SPHK1 has received considerable attention as a putative oncoprotein, SPHK2 has been much more difficult to study, with often conflicting data surrounding its role in cancer. Initial studies focused on non-haemopoietic malignancies, however a growing body of literature on the role of sphingolipid metabolism in haemopoietic malignancies is now emerging. This review provides an overview of the current state of knowledge of the SphKs and the bioactive lipid sphingosine 1-phosphate (S1P), the product of the reaction they catalyse. It then reviews the current literature regarding the roles of S1P and the SphKs in haemopoietic malignancies and discusses the compounds currently available that modulate sphingolipid metabolism and their potential and shortcomings as therapeutic agents for the treatment of haematological malignancies.
Keywords: Haematology; leukaemia; sphingosine kinase; sphingosine 1-phosphate
Rights: © 2013 John Wiley & Sons Ltd
RMID: 0030035406
DOI: 10.1111/bjh.12302
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.